AETHLON MEDICAL INC 8-K

What Happened

• Aethlon Medical, Inc. (AEMD) filed a Current Report on Form 8-K on June 10, 2026 to report its results of operations and financial condition (Item 2.02).
• The filing also contains a Regulation FD disclosure (Item 7.01) and incorporates a press release dated June 10, 2026 as an exhibit.

Key Details

• Filing date: June 10, 2026.
• Reported items: Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).
• Exhibits included: Exhibit 99.1 — Press Release (June 10, 2026); Exhibit 104 — Cover Page Interactive Data File (XBRL).

Why It Matters

• The 8‑K signals the company has publicly disclosed material information about its recent financial performance and operational condition; investors should read the attached press release (Exhibit 99.1) for the full details (revenues, earnings, cash position, or other metrics).
• Regulation FD disclosure indicates the company intended to make the information broadly available to all investors at the same time, reducing the risk of selective disclosure.
• Action for investors: review the press release and any accompanying financials for specifics, monitor subsequent filings (e.g., Form 10-Q or press updates) and market reaction for implications on valuation and near-term outlook.